New survey: The future of clinical studies – patient-oriented, decentralized, digital?

20.09.2022 10:41

The two software companies Climedo and Trialflow have published a joint survey on digital and patient-oriented applications within clinical studies. The global survey is aimed at study sponsors from medical technology, pharmaceuticals as well as contract research institutes and study centers.

Decentralized elements such as wearables, telemedicine or ePRO are increasingly being used in clinical studies. Patient recruitment is also increasingly taking place via digital channels. But how successfully are these tools actually used and where do sponsors and centers see the greatest potential? It deals with these and other questions new survey from Climedo and Trialflow. Consisting of 16 questions, it takes about five to ten minutes. The results will be published afterwards and also presented at a joint webinar at the end of October.

The survey covers the following areas:

• status quo: Which decentralized elements are used, which channels are used to recruit most successfully and what do companies and medical institutions particularly value in clinical studies?
• challenges: What makes clinical trials particularly difficult for centers and sponsors? What needs to be done so that the potential of digital tools can be exploited even better?
• Trends and perspectives: In which trends and technologies do participants see the greatest future potential? Where do you plan to recruit in the long term and to what extent do patient-oriented solutions provide added value?

“We work with many companies that want to conduct their studies with digital and patient-oriented solutions,” says Veronika Schweighart, co-founder and member of the management team at Climedo. “According to our survey on decentralized clinical trials in 2021, significant benefits have already been achieved, including resource savings and increased data quality. However, many companies still do not know where in the study process they should start with which optimization options and which tools bring real added value. We hope that our survey will shed more light on the current status, the biggest challenges and the most important future trends, and we look forward to numerous participants.”

“We are very pleased to be working with Climedo to gain better insights into the current challenges of implementing digital tools in clinical research,” said Leona Turner, co-founder and managing director of Trialflow. “Above all, we are looking forward to finding out more from the perspective of the study sponsors and the study centers. Good cooperation between these players is the necessary foundation for efficient study implementation.”

The survey is now open here available. Upon request, survey participants will receive the anonymized evaluation by email.

The first results will be presented as part of a joint English-language webinar on October 25th. Interested parties can here register for free.